Search - tctmd.com

Displaying 421 - 440 of 704

Sort: Relevancy | Date

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Prerecorded Case: Acute Stroke Intervention

Presenter: Leo Nelson Hopkins, Tudor G. Jovin

October 14, 2015

Presentation TCT 2015

What Cardiologists Need to Know Before Becoming Stroke Interventionalists II: How to Use Modern Neuro-Interventional Tools and Techniques to Optimize Stroke Outcomes

Presenter: Leo Nelson Hopkins, Tudor G. Jovin, Alex Abou-Chebl

October 14, 2015

Presentation TCT 2015

What Cardiologists Need to Know Before Becoming Stroke Interventionalists I: Basic Cerebrovascular Anatomy and Physiology and Differences Between the Cerebral and Coronary Arteries in Stroke

Presenter: Leo Nelson Hopkins, Tudor G. Jovin, Mark H. Wholey

October 14, 2015

Presentation TCT 2015

Interventional Manpower and Logistics in the New Era of Stroke Therapy: Should Cardiology Integrate Into the Stroke Team? If so, How?

Presenter: Leo Nelson Hopkins, Tudor G. Jovin, Klaus D. Mathias

October 14, 2015

Presentation TCT 2015

The Role of TPA in the Updated Stroke Approach

Presenter: Leo Nelson Hopkins, Tudor G. Jovin, Joshua Z. Willey

October 14, 2015

Presentation TCT 2015

Integrating Imaging Into the Clinical Decision Making in Acute Stroke

Presenter: Leo Nelson Hopkins, Tudor G. Jovin

October 14, 2015

Presentation TCT 2015

Defining the Elements, Workings, and Challenges of Developing a Truly Comprehensive Stroke Center

Presenter: Leo Nelson Hopkins, Tudor G. Jovin

October 14, 2015

Presentation TCT 2015

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes by the Rankin Scale

Presenter: Leo Nelson Hopkins, Tudor G. Jovin, Alex Abou-Chebl

October 14, 2015

Presentation TCT 2015

Featured Lecture: Endovascular Stroke Trials Go From Sorry to Sensational Practically Overnight Results, Analysis, and Implications for the Field

Presenter: Leo Nelson Hopkins, Tudor G. Jovin, Philip M. Meyers

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Presenter: William A. Gray, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek

October 14, 2015

Presentation TCT 2015

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Presenter: William A. Gray, D. Christopher Metzger, Piotr Musialek

October 14, 2015

Presentation TCT 2015

Update on the ACST-2 Trial: Early Outcomes and Perspectives on the Field From Across the Pond

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Presenter: William A. Gray, D. Christopher Metzger

October 14, 2015

Advertisement

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Low 1-Year Event Rates Seen After TAVR With Sapien 3

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Prerecorded Case: Acute Stroke Intervention

What Cardiologists Need to Know Before Becoming Stroke Interventionalists II: How to Use Modern Neuro-Interventional Tools and Techniques to Optimize Stroke Outcomes

What Cardiologists Need to Know Before Becoming Stroke Interventionalists I: Basic Cerebrovascular Anatomy and Physiology and Differences Between the Cerebral and Coronary Arteries in Stroke

Interventional Manpower and Logistics in the New Era of Stroke Therapy: Should Cardiology Integrate Into the Stroke Team? If so, How?

The Role of TPA in the Updated Stroke Approach

Integrating Imaging Into the Clinical Decision Making in Acute Stroke

Defining the Elements, Workings, and Challenges of Developing a Truly Comprehensive Stroke Center

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes by the Rankin Scale

Featured Lecture: Endovascular Stroke Trials Go From Sorry to Sensational Practically Overnight Results, Analysis, and Implications for the Field

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Update on the ACST-2 Trial: Early Outcomes and Perspectives on the Field From Across the Pond

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content